The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss

被引:47
作者
Ruban, Aruchuna [1 ]
Ashrafian, Hutan [1 ]
Teare, Julian P. [1 ]
机构
[1] Imperial Coll, Dept Surg & Canc, London, England
关键词
HUMAN GUT MICROBIOTA; GASTRIC BYPASS; BARIATRIC SURGERY; GLYCEMIC CONTROL; BILE-ACIDS; OBESITY; GLUCOSE; MULTICENTER; EFFICACY; MELLITUS;
D O I
10.1155/2018/7823182
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The rapid rise of obesity and type 2 diabetes poses a global threat to healthcare and is a major cause of mortality and morbidity. Bariatric surgery has revolutionised the treatment of both these conditions but is invasive and associated with an increased risk of complications. The EndoBarrier is a device placed endoscopically in the duodenum, which is designed to mimic the effects of gastric bypass surgery with the aim of inducing weight loss and improving glycaemic control. This review outlines the current clinical evidence of the device, its efficacy, potential mechanisms of action, and utility in clinical practice.
引用
收藏
页数:9
相关论文
共 40 条
[1]   Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass [J].
Ashrafian, H. ;
Athanasiou, T. ;
Li, J. V. ;
Bueter, M. ;
Ahmed, K. ;
Nagpal, K. ;
Holmes, E. ;
Darzi, A. ;
Bloom, S. R. .
OBESITY REVIEWS, 2011, 12 (501) :e257-e272
[2]   Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study [J].
Betzel, Bark ;
Homan, Jens ;
Aarts, Edo O. ;
Janssen, Ignace M. C. ;
de Boer, Hans ;
Wahab, Peter J. ;
Groenen, Marcel J. M. ;
Berends, Frits J. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (07) :2881-2891
[3]   The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation [J].
Cohen, Ricardo V. ;
Shikora, Scott ;
Petry, Tarissa ;
Caravatto, Pedro Paulo ;
Le Roux, Carel W. .
OBESITY SURGERY, 2016, 26 (08) :1989-1991
[4]   Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes [J].
de Jonge, Charlotte ;
Rensen, Sander S. ;
Verdam, Froukje J. ;
Vincent, Royce P. ;
Bloom, Steve R. ;
Buurman, Wim A. ;
le Roux, Carel W. ;
Schaper, Nicolaas C. ;
Bouvy, Nicole D. ;
Greve, Jan Willem M. .
OBESITY SURGERY, 2013, 23 (09) :1354-1360
[5]   Glucagon-like peptide-1 [J].
Doyle, ME ;
Egan, JM .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :377-399
[6]   Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrierA®): Outcomes in 114 Patients [J].
Forner, Patrice M. ;
Ramacciotti, Timothy ;
Farey, John E. ;
Lord, Reginald V. .
OBESITY SURGERY, 2017, 27 (12) :3306-3313
[7]   Differential Adaptation of Human Gut Microbiota to Bariatric Surgery-Induced Weight Loss Links With Metabolic and Low-Grade Inflammation Markers [J].
Furet, Jean-Pierre ;
Kong, Ling-Chun ;
Tap, Julien ;
Poitou, Christine ;
Basdevant, Arnaud ;
Bouillot, Jean-Luc ;
Mariat, Denis ;
Corthier, Gerard ;
Dore, Joel ;
Henegar, Corneliu ;
Rizkalla, Salwa ;
Clement, Karine .
DIABETES, 2010, 59 (12) :3049-3057
[8]   Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents [J].
Gasbjerg, Laerke Smidt ;
Gabe, Maria Buur Nordskov ;
Hartmann, Bolette ;
Christensen, Mikkel Bring ;
Knop, Filip Krag ;
Holst, Jens Juul ;
Rosenkilde, Mette Marie .
PEPTIDES, 2018, 100 :173-181
[9]   Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates [J].
Gersin, Keith S. ;
Rothstein, Richard I. ;
Rosenthal, Raul J. ;
Stefanidis, Dimitrios ;
Deal, Stephen E. ;
Kuwada, Timothy S. ;
Laycock, William ;
Adrales, Gina ;
Vassiliou, Melina ;
Szomstein, Samuel ;
Heller, Stephen ;
Joyce, Anne Marie ;
Heiss, Frederick ;
Neponmayshy, Dmitry .
GASTROINTESTINAL ENDOSCOPY, 2010, 71 (06) :976-982
[10]  
GID Release, 2017, GI DYN TOUTS NO COMP